Best Performing Pharma Stocks 2021 USA: FKnol.com

☀ Trending Among Corona Carnage ☀ List of Best Performing Corona Vaccine Stocks, Tech Penny Stocks, Healthcare Stocks, and Artificial Intelligence Stocks.
Medicines, drugs and medical devices have been the basic need of human population. The pharma industry aims to serve this fundamental need, by the discovery, production and marketing of the drugs that are aimed to prevent the diseases or offer treatment of the diseases to the mankind. Large and small pharma companies are running across the globe to produce drugs and other related pharma products, and lots of them have their stocks listed on the stock exchanges worldwide.
This allows for a good opportunity to common investors and traders to benefit from the pharma business. However, one must note that the pharma industry is heavily regulated, and approval or rejection of drugs, patent validity, factory conditions, competitor developments, and similar related parameters decide the fortune of the pharma companies.
Among the several pharma companies whose stocks are actively trading on the stock exchanges, which have been the winners in terms of highest returns?
This article provides a list of pharma stocks which have generated the highest returns in the year 2021 till date of writing. The list is prepared based on the percentage returns generated by the individual pharma stocks between the end of the previous and Oct 1, 2021, and the top 10 return generating pharma stocks are listed below.

Best Performing Stock Screener:

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.

Top Performing Pharma StocksAll Pharma StocksAll Pharma ETFsTop Dividend-paying Pharma StocksTop Pharma Stocks for Q4 2021

Top Pharma Stocks With Highest Returns

The following list presents stocks of the companies which belong to the broader Pharma sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized:

1) Immunome, Inc. (IMNM)

Price Gain: 108.26% 2021 year-to-date
Market Capitalization: $238.17 million
52-week Price Range: $9.27 - $63.78

2) Cerevel Therapeutics Holdings, Inc. (CERE)

Price Gain: 85.71% 2021 year-to-date
Market Capitalization: $4.46 billion
52-week Price Range: $9 - $39.61

3) Prestige Brand Holdings, Inc. (PBH)

Price Gain: 58.90% 2021 year-to-date
Market Capitalization: $2.77 billion
52-week Price Range: $32.2 - $60.57
List of ETFs holding PBH

4) Catalyst Pharmaceuticals, Inc. (CPRX)

Price Gain: 55.99% 2021 year-to-date
Market Capitalization: $536.52 million
52-week Price Range: $2.88 - $6.24
List of ETFs holding CPRX

5) Maravai LifeSciences Holdings, Inc. (MRVI)

Price Gain: 54.26% 2021 year-to-date
Market Capitalization: $4.95 billion
52-week Price Range: $23.62 - $63.55

6) Horizon Pharma plc (HZNP)

Price Gain: 50.20% 2021 year-to-date
Market Capitalization: $24.82 billion
52-week Price Range: $66.41 - $112.57
List of ETFs holding HZNP

7) Enanta Pharmaceuticals, Inc. (ENTA)

Price Gain: 44.80% 2021 year-to-date
Market Capitalization: $1.23 billion
52-week Price Range: $40.32 - $61.39
List of ETFs holding ENTA

8) C4 Therapeutics, Inc. (CCCC)

Price Gain: 38.73% 2021 year-to-date
Market Capitalization: $2.23 billion
52-week Price Range: $22.4 - $51.21

9) Bausch Health Companies Inc. (BHC)

Price Gain: 37.50% 2021 year-to-date
Market Capitalization: $10.26 billion
52-week Price Range: $15.28 - $34.8
List of ETFs holding BHC

10) Innoviva, Inc. (INVA)

Price Gain: 37.37% 2021 year-to-date
Market Capitalization: $1.18 billion
52-week Price Range: $9.21 - $17.45
List of ETFs holding INVA

There's more... See price performance, YTD-gains, market-cap and other details of all the 97 Pharma stocks with sorting features in a tabular format.
☀ Trending Among Corona Carnage ☀ List of Best Performing Corona Vaccine Stocks, Tech Penny Stocks, Healthcare Stocks, and Artificial Intelligence Stocks.
Alternatively, one can also explore the List of Top Pharma ETFs.

Best Performing Stock Screener:

Top Performing Pharma StocksAll Pharma StocksAll Pharma ETFsTop Dividend-paying Pharma StocksTop Pharma Stocks for Q4 2021

Performance of Top Pharma Stocks

Here's a look at the basic details and how the above mentioned stocks fared during the period:

Immunome, Inc.

Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Immunome, Inc..
The Exton, United States-headquartered company Immunome, Inc. (IMNM) is ranked number one among the best performing stocks of Pharma of 2021. The Healthcare sector business falls under the Biotechnology industrial sub-sector. Since the start of the year 2021, the stock price of Immunome, Inc. has changed by 108.26 percent, which is calculated based on the previous year's closing price of $9.68 per share and year-to-date closing price of $20.16 per share as of writing. The market value of the company as indicated by its market-cap changed from $102.04 million to $238.17 million during the same period. Along with Pharma, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Biotech, Healthcare, among other usual products and services.

Cerevel Therapeutics Holdings,

Cerevel Therapeutics Holdings, Inc. operates as a clinical-stage biopharmaceutical company that engages in the development of various therapies ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Cerevel Therapeutics Holdings, .
The Cambridge, United States-based Healthcare sector company Cerevel Therapeutics Holdings, Inc. (CERE) holds the number two spot among the best performing stocks of the Pharma sector. Classified as the Biotechnology business, the stock price of Cerevel Therapeutics Holdings, ended the previous year at a price of $16.58 per share while it reached the level of $30.79 apiece as of Oct 1, 2021 translating to a percentage change in stock price of 85.71%. As of writing, the company's market-cap value stands at $4.46 billion.

Prestige Brand

Prestige Brands Holdings, Inc., incorporated on June 24, 2004, is engaged in the marketing, sales and distribution of over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Prestige Brand.
During the given months of the year 2021, Prestige Brand Holdings, Inc. (PBH) was successful in generating YTD returns of 58.9 percentage which helped it gain the number three spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the New York, NY-based Prestige Brand closed at a price of $34.87 per share, while it traded at a price of $55.41 per share as of Oct 1, 2021. The company's market cap changed from $1.75 billion to $2.77 billion during the same period YTD. It ranks as a key constituent of major indexes that include Wilshire 5000 index, and several other broader level multi-cap market indicators. The company is classified under the Healthcare industry sector and further specialized as a Major Pharmaceuticals sector business.

Catalyst Pharma

Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., incorporated on July 21, 2006, is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Catalyst Pharma.
The Florida, FL-based Catalyst Pharmaceuticals, Inc. (CPRX) belongs to the Healthcare sector and is categorized as a Major Pharmaceuticals company. The stock of Catalyst Pharma ended the previous year at a price of $3.34 per share. As of Oct 1, 2021, the stock price has reached $5.21 apiece, which indicates a change of 55.99 percent making the company rank among the top performing stocks of the Pharma for the year 2021 till date. At the end of the last year, company's market capitalization stood at $346.18 million. It has now changed to $536.52 million as of writing. Catalyst Pharma continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and several other broader level multi-cap market indicators.

Maravai LifeSciences Holdings,

Maravai LifeSciences Holdings, Inc. operates as a life sciences company that provides products to enable the development of drug therapies, ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Maravai LifeSciences Holdings, .
Rank number five in the coveted list is held by Maravai LifeSciences Holdings, Inc. (MRVI) for being among the top performing stocks of 2021. Headquartered in San Diego, United States, the Healthcare sector company is categorized under the industrial sub-sector of Biotechnology. Since the start of the year 2021, stock of Maravai LifeSciences Holdings, has so far gained 54.26 percentage, based on the previous year's closing price of $28.05 per share and year-to-date price of $43.27 per share. During the same period, the market capitalization of the company changed from $7.01 billion to $4.95 billion.

Horizon Pharma

Horizon Pharma Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Horizon Pharma.
At number six in the list of top stocks stands Horizon Pharma plc (HZNP), which saw a change in its stock price from the level of $73.15 apiece during previous year December end to the price of $109.87 per share as of Oct 1, 2021. It translates to a change of 50.2 percentage. The Ireland-headquartered Healthcare sector company also saw its market value change from $16.15 billion to $24.82 billion. The Major Pharmaceuticals specialist also managed to outperform some of the major stock market indexes of which it is a part of. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.

Enanta Pharma

Enanta Pharmaceuticals, Inc., incorporated on July 25, 1995, is a research and development-focused biotechnology company. The Company uses chemistry-driven approach and drug discovery solutions to create small molecule drugs for ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Enanta Pharma.
Enanta Pharmaceuticals, Inc. (ENTA) has moved by 44.8 percentage over the given period of 2021-YTD, helping it gain a place at number seven among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $42.1 apiece to the price of $60.96 per share between the end of December of the previous year and Oct 1, 2021. The smart run of the Massachusetts, MA-based Major Pharmaceuticals sector company lead to a handsome gain in its marketcap which changed from $845.32 million to $1.23 billion over the same duration. Enanta Pharma is a key member of many popular stock market indexes. They include Wilshire 5000 index, and several other broader level multi-cap market indicators.

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a biopharmaceutical company, develops novel therapeutic candidates to target and destroy disease-causing proteins for the ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of C4 Therapeutics, Inc..
Based on the market-cap change from $1.43 billion to $2.23 billion during the given months of the year 2021 and the share price change from $33.13 per share to a price of $45.96 per share as of Oct 1, 2021, C4 Therapeutics, Inc. (CCCC) was successful in generating YTD returns of 38.73 percentage. Standing at the number eight rank in the top performing list of Pharma stocks, the Watertown, United States-based C4 Therapeutics, Inc. is categorized as the Biotechnology sub-sector business which falls under the larger Healthcare sector.

Bausch Health Companies

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Bausch Health Companies.
Bausch Health Companies (BHC) generated percentage returns of 37.5 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $20.8 per share from the previous year-end to the price of $28.6 per share as of Oct 1, 2021. The company's value, as indicated by the market-cap figure, changed from $7.33 billion to $10.26 billion during the same period.
The company is categorized as a Healthcare speciality business with further classification in the Healthcare sub-category. Based in Laval, QC, the YTD performance of the Pharma sector also fared better than that of the returns generated by some of the closley tracked stock market indexes.

Innoviva

Innoviva, Inc., formerly Theravance, Inc., incorporated on November 19, 1996, focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Innoviva.
The number ten spot in the list of top performing stocks of the Pharma sector is taken by Innoviva, Inc. (INVA). The company's stock price changed from $12.39 per share at the end of December of the previous year to the price of $17.02 per share as of writing. Overall, the stock managed to realized price change of 37.37 percent during the given time period. The corresponding change in the market capitalization value of the California, CA-based Healthcare sector company was from $1.26 billion to $1.18 billion. Being ranked in the top 10 best performing stocks of the Pharma sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes. They include the Wilshire 5000 index, and a handful of other multi-capitalization indexes.

This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.